Chromatin unwinding state for in situ identification and lineage tracing of circulating tumor cells
The detection of circulating tumor cells (CTCs) through liquid biopsy offers a non‐invasive approach for accurately monitoring cancer dissemination and evaluating therapeutic efficiency. However, their rarity and heterogeneity limit conventional tumor antigen labelling‐based methods in identifying and tracing CTCs.
Bin Ye +32 more
wiley +1 more source
CTC together with Shh and Nrf2 are prospective diagnostic markers for HNSCC [PDF]
Mizanur Rahman +23 more
openalex +1 more source
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid +4 more
wiley +1 more source
Translating Liquid Biopsy into Practice- The Promise and Challenges of Circulating Tumor Cells in Ovarian and Lung Cancer Management. [PDF]
Mustafa N +6 more
europepmc +1 more source
Identifying novel treatments for diabetic management is always a competitive research topic all over the world. PPAR‐γ is one of the key regulators involved in glucose and lipid metabolism and improves insulin sensitivity and glucose homeostasis. This study investigated the impacts of 639 traditional Chinese medicine (TCM) on PPAR‐γ gene promoter ...
Mingyuan Dou +9 more
wiley +1 more source
Circulating Tumour Cells as Potential Biomarkers for Oral Squamous Cell Carcinoma. [PDF]
Mabongo M +5 more
europepmc +1 more source
Circulating Tumor Cells: Clinically Relevant Molecular Access Based on a Novel CTC Flow Cell
Jessamine Winer‐Jones +14 more
openalex +2 more sources
Synergistic effects of microplastic and Vibrio harveyi co‐exposure on big‐belly seahorse (Hippocampus abdominalis). Seahorses were exposed to microplastics (50 beads/L of 0.2 μm SMP and 1.0 μm LMP) and injected with V. harveyi (1 × 103 CFU/mL).
Jin A Kim +4 more
wiley +1 more source
HDAC inhibitor tucidinostat and metronomic capecitabine plus endocrine therapy for patients with HR-positive HER2-negative advanced breast cancer after CDK4/6 inhibitors treatment: clinical findings and exploratory circulating tumor cell and ctDNA biomarker analyses of a multicenter, phase 2 study (SYSUCC-020 trial). [PDF]
Wu HL +18 more
europepmc +1 more source
EP1.01-27 Preliminary Study on Immune Checkpoint and EMT Feature of CTCs in Advanced Non-Small Cell Lung Cancer Patients [PDF]
L. Zhang +6 more
openalex +1 more source

